ConductScience.org, home

Trial · NCT01112358

Outcomes16

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Oocytes RetrievedAt the end of stimulation (Day 2 up to Day 8)ITT populationOocytesMEAN
PRIMARYNumber of Follicles Greater Than (>) 14 Millimeter (mm) in DiameterAt the end of stimulation (Day 2 up to Day 8)ITT populationFolliclesMEAN
PRIMARYOocytes Recovery RateAt the end of stimulation (Day 2 up to Day 8)ITT populationoocytes per >14 mm follicleMEAN
SECONDARYOocyte Nuclear Maturity RateAt the end of stimulation (Day 2 up to Day 8)ITT populationmetaphase II oocytes/retrieved oocyteMEAN
SECONDARYFertilization RateUp to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8)ITT population2PN fertilized oocyte/inseminated oocyteMEAN
SECONDARYNumber of Embryos by QualityUp to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8)ITT populationEmbroysMEAN
SECONDARYNumber of Embryos Transferred by In Vitro Fertilization (IVF)Up to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8)ITT populationEmbroysMEAN
SECONDARYNumber of Participants With Positive Pregnancy TestUp to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8)ITT populationParticipantsNUMBER
SECONDARYNumber of Participants With Clinical PregnancyUp to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8)ITT populationParticipantsNUMBER
SECONDARYImplementation RateUp to 35-45 days after administration of r-hCG (r-hCG administration = Day 2 to Day 8)ITT populationClinical pregnancy/embryo transferredNUMBER
SECONDARYPlasma Level of EstradiolAt the time of r-hCG administration (any days between Day 2 to Day 8)ITT populationPicograms per milliliters (pg/mL)MEAN
SECONDARYEndometrial ThicknessAt the time of r-hCG administration (any days between Day 2 to Day 8)ITT populationmillimeters (mm)MEAN
SECONDARYDuration of Ovarian StimulationRandomization to Day 8ITT populationdaysMEAN
SECONDARYrFSH Cumulative DoseRandomization to Day 8ITT populationIUMEAN
SECONDARYPlasma Levels of LHAt the time of r-hCG administration (any days between Day 2 to Day 8)ITT populationIU per liter (IU/L)MEAN
SECONDARYNumber of Participants in Whom At Least 1 Stimulation Cycle Was CancelledRandomization to Day 8ITT populationParticipantsNUMBER

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01112358/outcomes